Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 6.2.2024Baxalta Innovations GmbH (BXA)5730AHyQvia 100 mg/ml infúzny roztok na subkutánne použitie (sol inf 1x25 ml (10 % IG)+1x1,25 ml (rHuPH20) (liek.inj.skl.))6.2.2024R
 6.2.2024Upjohn EESV (UPO-NL)62568Norvasc 10 mg tablety (tbl 30x10 mg (blis.PVC/PVDC/Al))6.2.2024R
 5.2.2024Baxalta Innovations GmbH (BXA)9627DADYNOVI 3 000 IU/5 ml prášok a rozpúšťadlo na injekčný roztok (plv iol 1x3 000 IU + 1xsolv.5 ml (liek.inj.skl.+spojené s pomôckou na rekonšt.))6.2.2024U
 5.2.2024ALPEX PHARMA (IRL) LIMITED (APX-IE)00115Oramellox 15 mg (tbl oro 30(3x10)x15 mg (blis.Al/PA/Al/PVC))29.1.2024O
 2.2.2024Actavis Group PTC ehf. (ACT-10)5275ANemdatine 20 mg filmom obalené tablety (tbl flm 56x20 mg (blis.PVC/PVDC/Al))2.2.2024O
 2.2.2024Teva B.V. (TEV-NL-4)92667Lamotrigin Actavis 25 mg (tbl dsp 30x25 mg (blis.PVDC/Al))2.2.2024O
 2.2.2024ratiopharm GmbH (RAT)44195Fentanyl ratiopharm 12 µg/h (emp tdm 5x12 µg/1 h (vre.papier/PE/Al/surlyn))18.3.2024R
 2.2.2024Teva B.V. (TEV-NL-4)91376Gabapentin-Teva 300 mg (cps dur 200(2x100)x300 mg (blis.PVC/PVDC/Al))4.3.2024R
 2.2.2024TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3383AEplerenone Teva 50 mg (tbl flm 90x1x50 mg (blis.PVC/PVDC/Al perf.))23.2.2024R
 2.2.2024Cassella-med GmbH & Co. KG (CSM)8607CSoledum 100 mg mäkké gastrorezistentné kapsuly (cps enm 20x100 mg (blis.PVC/PVDC/Al))1.2.2024R
 2.2.2024M.C.M. Klosterfrau Vertriebsgesellschaft mbH (MCM-1)66928MELISANA Klosterfrau (sol pdr 1x155 ml (fľ.skl.))1.7.2024R
 2.2.2024Teva B.V. (TEV-NL-4)95236Sertralin Actavis 100 mg (tbl flm 30x100 mg (blis.PVC/Al))8.1.2024O
 2.2.2024Bristol-Myers Squibb/Pfizer EEIG (BMS-IE-1)08363Eliquis 2,5 mg filmom obalené tablety (tbl flm 20x2,5 mg (blis.PVC/PVDC/Al))12.2.2024Z
 2.2.2024ARDEZ Pharma, spol. s r.o. (ARZ)2436DTedez (cps dur 90x0,5 mg/0,4 mg (fľ.HDPE))5.2.2024O
 2.2.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)3868ESeHCAT 370 kBq tvrdá kapsula (cps dur 1x370 kBq (obal polystyrénový))2.2.2024U

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)